Researchers are excited about the medication , a groundbreaking dual agonist showing remarkable data in initial trials for weight loss . It acts by impacting two systems: GLP-1 and GIP, these, when https://siobhankcei051894.dm-blog.com/41060350/a-new-prospect-for-size-reduction